Evidence map›Paper›PMID 41335522›Full record

ArticleMicrobiologyOpen2025

Antiproliferative Activity of Prodigiosin Derived From Serratia marcescens VITSD2: An In Vitro and In Silico Approach.

Shah Alam, Suraj Kumar Nag, Jemima Naine S, Mohanapriya A, Sreelakshmi R Nair, Tamil Bharathi Palanisamy, Mohanasrinivasan V, Subathra Devi C

Abstract read
In one paragraph

Article in MicrobiologyOpen, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. A Novel Indigoidine-like NRPS Gene fromAntioxidants (Basel, Switzerland) · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shah AlamSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Suraj Kumar NagSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Jemima Naine SSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Mohanapriya ASchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Sreelakshmi R NairSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Tamil Bharathi PalanisamySchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Mohanasrinivasan VSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.
Subathra Devi CSchool of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.ORCID 0000-0002-1828-8212

Funding

The authors received no specific funding for this work.
6 · The paper itself

Abstract

The red color pigment prodigiosin is a potent antioxidant produced by different strains of Serratia marcescens and other bacteria. The bio pigment demonstrates many hopeful impending bioactivities. Prodigiosin is an active proapoptotic agent against various cancer cell lines. In the present study, pigment produced from soil isolate Serratia marcescens VITSD2 was characterized and identified using UV, FTIR, GC-MS and NMR analysis (

Indexed as

Antineoplastic AgentsCell ProliferationProdigiosinSerratia marcescensAntioxidantsCell Line, TumorGas Chromatography-Mass SpectrometryHumansMagnetic Resonance SpectroscopyMolecular Docking SimulationSoil MicrobiologyAntineoplastic AgentsAntioxidantsProdigiosinanticancerantioxidantHep‐G2pigmentsprodigiosinSerratia marcescens VITSD2

Identifiers

PMID41335522
PMCPMC12674088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.